"Pemphigoid, Bullous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
Descriptor ID |
D010391
|
MeSH Number(s) |
C17.800.865.690 C20.111.730
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pemphigoid, Bullous".
Below are MeSH descriptors whose meaning is more specific than "Pemphigoid, Bullous".
This graph shows the total number of publications written about "Pemphigoid, Bullous" by people in this website by year, and whether "Pemphigoid, Bullous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2017 | 16 | 1 | 17 |
2018 | 9 | 0 | 9 |
2019 | 3 | 0 | 3 |
2020 | 3 | 0 | 3 |
2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pemphigoid, Bullous" by people in Profiles.
-
Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol. 2022 Jan; 49(1):34-41.
-
Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination. J Allergy Clin Immunol. 2021 Sep; 148(3):750-751.
-
The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? J Eur Acad Dermatol Venereol. 2021 Oct; 35(10):e645-e647.
-
[Bullous pemphigoid and COVID-19 vaccine]. Med Clin (Barc). 2021 11 26; 157(10):e333-e334.
-
COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation. J Eur Acad Dermatol Venereol. 2021 Jul; 35(7):e418-e421.
-
The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study. J Am Acad Dermatol. 2021 07; 85(1):79-87.
-
Immunobullous diseases, prothrombotic state, and COVID-19: Role of prophylactic anticoagulation in bullous pemphigoid and pemphigus. Dermatol Ther. 2020 Nov; 33(6):e14361.
-
Patients with bullous disorders during COVID-19 period: Management and adherence to treatment. Dermatol Ther. 2020 11; 33(6):e13697.
-
Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era. Dermatol Ther. 2020 Nov; 33(6):e13956.
-
Patients with bullous skin disease in a high-epidemic COVID-19 area, Bergamo, Italy. Br J Dermatol. 2020 Sep; 183(3):589-591.